Castuner
Engadir un podcast

Keeping Current

Medscape Podcasts

Experts discuss relevant and actionable strategies for practice improvement as well as timely clinical topics.

Web do podcast

Escóitao na túa aplicación

Episodios

634 episodios

  1. European Alzheimer's Care: A Live, Case-Based Forum on Amyloid-Targeting Therapy 55:04
  2. Deciphering Clinical Data in Transthyretin Cardiac Amyloidosis for Today's Clinical Practice 31:14
  3. Frontiers in Modern Oncology: Molecular-Guided Strategies for HR-Positive/HER2-Negative Metastatic Breast Cancer 28:14
  4. Navigating IgA Nephropathy Management in an Evolving Treatment Landscape: Key Considerations for Treatment Selection 45:43
  5. Antibody-Drug Conjugate Therapy for Early Breast Cancer: Innovations That Shape the Future of Care 31:56
  6. Solving the Alzheimer's Disease Biomarker Puzzle: Live, European Peer Workshop 36:28
  7. Advancing Uveitic Macular Edema Management: What's New? 32:09
  8. Patient Journeys With IgA Nephropathy: Optimizing Outcomes in Patient Care 59:36
  9. Refining Adjuvant Therapy in HR-Positive/HER2-Negative Early Breast Cancer: Personalizing Care in the CDK4/6 Inhibitor Era 52:11
  10. The Patient Journey With Severe Refractory Autoimmune Rheumatic Diseases: Exploring the Potential for CAR T-Cell Therapies 48:44
  11. Translating Molecular Insights Into Practice for HR-Positive/HER2-Negative Metastatic Breast Cancer 35:38
  12. Targeting the Metabolic Driver: A Forward-Looking Approach to Obesity and Liver Health 29:23
  13. The Whole Patient: Integrating the Lived Experience of Myasthenia Gravis 42:15
  14. Epilepsy in General Neurology Practice: Optimizing a Therapeutic Approach From the Start 47:35
  15. Myasthenia Gravis Guidelines: A Global View for Local Practice 38:12
  16. From Mechanism to Management: Applying Evidence for Hemophilia A in the Clinic 18:01
  17. Updating Our Checklist for Transthyretin Amyloid Cardiomyopathy Monitoring 41:36
  18. Mild Cognitive Impairment and Mild Dementia: Can We Act Before It's Too Late? 39:21
  19. Why Target APRIL in IgA Nephropathy Management? Get Up to Speed With the Mechanisms of Action and Key Data 27:56
  20. Beyond Intervals: The Next Era of Continuous Delivery in Retinal Medicine 32:28
  21. When and How Should I Optimize Heart Failure Treatments for My Patients? 26:07
  22. The Evolving Diagnostic and Management Landscape for Progressive Familial Intrahepatic Cholestasis 35:35
  23. Pharmacological and Combination Interventions for Nicotine Cessation 33:24
  24. Is Normalizing Hemostasis an Achievable Goal in Hemophilia A? 29:31
  25. The Top 5 Errors in Transthyretin Amyloid Cardiomyopathy Management 17:41
  26. Better Drying? Longer Lasting? Second-Generation Anti-VEGF Therapies in Clinical Practice 37:03
  27. Shaping the Future of Precision Oncology: Biomarker-Driven Care for Tumor-Agnostic Therapies 23:21
  28. Navigating the Management of Alagille Syndrome Using Ileal Bile Acid Transporter (IBAT) Inhibitors 21:55
  29. Chronic Inflammatory Demyelinating Polyradiculoneuropathy Care Partnerships: Aligning Goals for Better Outcomes 26:15
  30. The Molecular Nuances of Hemostasis: Differentiating FVIII and Non-Factor Replacement 29:13
  31. Depression and Neurological Diseases: What's the Link? 22:29
  32. What Lies Beneath Generalized Myasthenia Gravis: Exploring Novel Mechanisms of Action of Emerging Therapies 31:16
  33. Charting New Frontiers in Advanced Breast Cancer: Milestones, Missions, and Mastery 1:16:10
  34. Beyond SGLT2: The Emerging Role of Dual SGLT1/2 Inhibition in Heart Failure 29:49
  35. Addressing Unmet Needs in the Management of Sjögren's Disease: A Spotlight on Emerging Biologic Therapies 30:40
  36. Challenges and Opportunities in the Diagnostic Pathway for Biliary Atresia 35:33
  37. Diabetic Macular Edema: Express Q&A on What's New 16:57
  38. The Science of SGLT1 and SGLT2: Unpacking Dual Inhibition for Heart Failure 17:14
  39. Liver Fibrosis in Type 2 Diabetes and Obesity: A Case-Based Approach 21:05
  40. Clinical Perspectives on the Use of PI3K/AKT Pathway Inhibitors in the Management of HR+/HER2− Metastatic Breast Cancer 36:15
  41. New Horizons in Uveitic Macular Edema 33:32
  42. Metabolic Crossroads: Navigating the Obesity–Liver Disease Axis 51:20
  43. Beyond the Update in Advanced/Recurrent Endometrial Cancer: How Evidence Is Shaping New Guidelines 37:09
  44. Beyond PSMA: Preparing Your Practice for the Next Wave of Prostate Cancer Biomarkers 31:04
  45. Avoiding Common Mistakes in Managing Focal Epilepsy 19:08
  46. From Prescription to Practice in Respiratory Diseases: Overcoming Barriers to Inhaler Adherence and Compliance 35:16
  47. The CLL Consultation: Partnering With Patients for Person-Centred Care 35:34
  48. Immunotherapy for Non-Muscle-Invasive Bladder Cancer: Expert Takeaways From the Latest Updates 37:26
  49. Navigating the HER2 Spectrum in Breast Cancer: Evolving Diagnostic Paradigms for Clinical Excellence 33:46
  50. 2025 Winter Conference Update: Novel and Emerging Treatment Strategies for Breast Cancer 36:58